$5.74 - GALT | Galectin Therapeutics Inc.

Galectin Therapeutics Inc. (GALT)

Galectin Therapeutics Inc.

XNAS:GALT

5.74

-8.89%

Ask

$7.46 - 100.00

Bid

$5.03 - 100.00

Low

$5.67

High

$6.66

Open

$6.35

Prev Close

$6.3

52W High

6.66

52W Low

0.73

Volume

774091

Avg Vol (3m)

382736.7

Float

45762048.87

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2834

Sector: Health Technology

Industry: Biotechnology

Date Listed: 09/04/2002

Primary Exchange: XNAS

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Phone: 678-620-3186

Address: 4960 Peachtree Industrial Boulevard

Address 2: Suite 240

City: Norcross

State: GA

Postal Code: 30071

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-9.710000

P/B (TTM)

-2.941900

EPS

-0.13

Round Lot

100

Composit FIGI

BBG000BK6FP5

Share Class FIGI

BBG001S9NYW2

Share Class Shares Outstanding

64.06M

Weighted Shares Outstanding

64.48M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion